List With HCPCS Codes For Inhalation Solutions

The HCPCS codes for Inhalation Solutions range from J7604 to J7686. These codes represent various inhalation solutions used for respiratory treatments. Each code describes a specific medication, its form, dosage, and administration method.

1. HCPCS Code J7604

HCPCS J7604 describes Acetylcysteine, an inhalation solution that is a compounded product administered through durable medical equipment (DME) in unit dose form per gram.

2. HCPCS Code J7605

HCPCS J7605 describes Arformoterol, an inhalation solution that is an FDA-approved final product, non-compounded, administered through DME in unit dose form at a dosage of 15 micrograms.

3. HCPCS Code J7606

HCPCS J7606 describes Formoterol fumarate, an inhalation solution that is an FDA-approved final product, non-compounded, administered through DME in unit dose form at a dosage of 20 micrograms.

4. HCPCS Code J7607

HCPCS J7607 describes Levalbuterol, an inhalation solution that is a compounded product administered through DME in concentrated form at a dosage of 0.5 mg.

5. HCPCS Code J7608

HCPCS J7608 describes Acetylcysteine, an inhalation solution that is an FDA-approved final product, non-compounded, administered through DME in unit dose form per gram.

6. HCPCS Code J7609

HCPCS J7609 describes Albuterol, an inhalation solution that is a compounded product administered through DME in unit dose form at a dosage of 1 mg.

7. HCPCS Code J7610

HCPCS J7610 describes Albuterol, an inhalation solution that is a compounded product administered through DME in concentrated form at a dosage of 1 mg.

8. HCPCS Code J7611

HCPCS J7611 describes Albuterol, an inhalation solution that is an FDA-approved final product, non-compounded, administered through DME in concentrated form at a dosage of 1 mg.

9. HCPCS Code J7612

HCPCS J7612 describes Levalbuterol, an inhalation solution that is an FDA-approved final product, non-compounded, administered through DME in concentrated form at a dosage of 0.5 mg.

10. HCPCS Code J7613

HCPCS J7613 describes Albuterol, an inhalation solution that is an FDA-approved final product, non-compounded, administered through DME in unit dose form at a dosage of 1 mg.

11. HCPCS Code J7614

HCPCS J7614 describes Levalbuterol, an inhalation solution that is an FDA-approved final product, non-compounded, administered through DME in unit dose form at a dosage of 0.5 mg.

12. HCPCS Code J7615

HCPCS J7615 describes Levalbuterol, an inhalation solution that is a compounded product administered through DME in unit dose form at a dosage of 0.5 mg.

13. HCPCS Code J7620

HCPCS J7620 describes a combination of Albuterol (up to 2.5 mg) and ipratropium bromide (up to 0.5 mg), an FDA-approved final product, non-compounded, administered through DME.

14. HCPCS Code J7622

HCPCS J7622 describes Beclomethasone, an inhalation solution that is a compounded product administered through DME in unit dose form per milligram.

15. HCPCS Code J7624

HCPCS J7624 describes Betamethasone, an inhalation solution that is a compounded product administered through DME in unit dose form per milligram.

16. HCPCS Code J7626

HCPCS J7626 describes Budesonide, an inhalation solution that is an FDA-approved final product, non-compounded, administered through DME in unit dose form up to 0.5 mg.

17. HCPCS Code J7627

HCPCS J7627 describes Budesonide, an inhalation solution that is a compounded product administered through DME in unit dose form up to 0.5 mg.

18. HCPCS Code J7628

HCPCS J7628 describes Bitolterol mesylate, an inhalation solution that is a compounded product administered through DME in concentrated form per milligram.

19. HCPCS Code J7629

HCPCS J7629 describes Bitolterol mesylate, an inhalation solution that is a compounded product administered through DME in unit dose form per milligram.

20. HCPCS Code J7631

HCPCS J7631 describes Cromolyn sodium, an inhalation solution that is an FDA-approved final product, non-compounded, administered through DME in unit dose form per 10 milligrams.

21. HCPCS Code J7632

HCPCS J7632 describes Cromolyn sodium, an inhalation solution that is a compounded product administered through DME in unit dose form per 10 milligrams.

22. HCPCS Code J7633

HCPCS J7633 describes Budesonide, an inhalation solution that is an FDA-approved final product, non-compounded, administered through DME in concentrated form per 0.25 milligram.

23. HCPCS Code J7634

HCPCS J7634 describes Budesonide, an inhalation solution that is a compounded product administered through DME in concentrated form per 0.25 milligram.

24. HCPCS Code J7635

HCPCS J7635 describes Atropine, an inhalation solution that is a compounded product administered through DME in concentrated form per milligram.

25. HCPCS Code J7636

HCPCS J7636 describes Atropine, an inhalation solution that is a compounded product administered through DME in unit dose form per milligram.

26. HCPCS Code J7637

HCPCS J7637 describes Dexamethasone, an inhalation solution that is a compounded product administered through DME in concentrated form per milligram.

27. HCPCS Code J7638

HCPCS J7638 describes Dexamethasone, an inhalation solution that is a compounded product administered through DME in unit dose form per milligram.

28. HCPCS Code J7639

HCPCS J7639 describes Dornase alfa, an inhalation solution that is an FDA-approved final product, non-compounded, administered through DME in unit dose form per milligram.

29. HCPCS Code J7640

HCPCS J7640 describes Formoterol, an inhalation solution that is a compounded product administered through DME in unit dose form at a dosage of 12 micrograms.

30. HCPCS Code J7641

HCPCS J7641 describes Flunisolide, an inhalation solution that is a compounded product administered through DME in unit dose form per milligram.

31. HCPCS Code J7642

HCPCS J7642 describes Glycopyrrolate, an inhalation solution that is a compounded product administered through DME in concentrated form per milligram.

32. HCPCS Code J7643

HCPCS J7643 describes Glycopyrrolate, an inhalation solution that is a compounded product administered through DME in unit dose form per milligram.

33. HCPCS Code J7644

HCPCS J7644 describes Ipratropium bromide, an inhalation solution that is an FDA-approved final product, non-compounded, administered through DME in unit dose form per milligram.

34. HCPCS Code J7645

HCPCS J7645 describes Ipratropium bromide, an inhalation solution that is a compounded product administered through DME in unit dose form per milligram.

35. HCPCS Code J7647

HCPCS J7647 describes Isoetharine HCl, an inhalation solution that is a compounded product administered through DME in concentrated form per milligram.

36. HCPCS Code J7648

HCPCS J7648 describes Isoetharine HCl, an inhalation solution that is an FDA-approved final product, non-compounded, administered through DME in concentrated form per milligram.

37. HCPCS Code J7649

HCPCS J7649 describes Isoetharine HCl, an inhalation solution that is an FDA-approved final product, non-compounded, administered through DME in unit dose form per milligram.

38. HCPCS Code J7650

HCPCS J7650 describes Isoetharine HCl, an inhalation solution that is a compounded product administered through DME in unit dose form per milligram.

39. HCPCS Code J7657

HCPCS J7657 describes Isoproterenol HCl, an inhalation solution that is a compounded product administered through DME in concentrated form per milligram.

40. HCPCS Code J7658

HCPCS J7658 describes Isoproterenol HCl, an inhalation solution that is an FDA-approved final product, non-compounded, administered through DME in concentrated form per milligram.

41. HCPCS Code J7659

HCPCS J7659 describes Isoproterenol HCl, an inhalation solution that is an FDA-approved final product, non-compounded, administered through DME in unit dose form per milligram.

42. HCPCS Code J7660

HCPCS J7660 describes Isoproterenol HCl, an inhalation solution that is a compounded product administered through DME in unit dose form per milligram.

43. HCPCS Code J7665

HCPCS J7665 describes Mannitol, an inhalation solution administered through an inhaler at a dosage of 5 mg.

44. HCPCS Code J7667

HCPCS J7667 describes Metaproterenol sulfate, an inhalation solution that is a compounded product in concentrated form per 10 milligrams.

45. HCPCS Code J7668

HCPCS J7668 describes Metaproterenol sulfate, an inhalation solution that is an FDA-approved final product, non-compounded, administered through DME in concentrated form per 10 milligrams.

46. HCPCS Code J7669

HCPCS J7669 describes Metaproterenol sulfate, an inhalation solution that is an FDA-approved final product, non-compounded, administered through DME in unit dose form per 10 milligrams.

47. HCPCS Code J7670

HCPCS J7670 describes Metaproterenol sulfate, an inhalation solution that is a compounded product administered through DME in unit dose form per 10 milligrams.

48. HCPCS Code J7674

HCPCS J7674 describes Methacholine chloride, an inhalation solution administered through a nebulizer at a dosage of 1 mg. (Terminated)

49. HCPCS Code J7676

HCPCS J7676 describes Pentamidine isethionate, an inhalation solution that is a compounded product administered through DME in unit dose form per 300 mg.

50. HCPCS Code J7677

HCPCS J7677 describes Revefenacin inhalation solution, an FDA-approved final product, non-compounded, administered through DME at a dosage of 1 microgram.

51. HCPCS Code J7680

HCPCS J7680 describes Terbutaline sulfate, an inhalation solution that is a compounded product administered through DME in concentrated form per milligram.

52. HCPCS Code J7681

HCPCS J7681 describes Terbutaline sulfate, an inhalation solution that is a compounded product administered through DME in unit dose form per milligram.

53. HCPCS Code J7682

HCPCS J7682 describes Tobramycin, an inhalation solution that is an FDA-approved final product, non-compounded, administered through DME in unit dose form per 300 milligrams.

54. HCPCS Code J7683

HCPCS J7683 describes Triamcinolone, an inhalation solution that is a compounded product administered through DME in concentrated form per milligram.

55. HCPCS Code J7684

HCPCS J7684 describes Triamcinolone, an inhalation solution that is a compounded product administered through DME in unit dose form per milligram.

56. HCPCS Code J7685

HCPCS J7685 describes Tobramycin, an inhalation solution that is a compounded product administered through DME in unit dose form per 300 milligrams.

57. HCPCS Code J7686

HCPCS J7686 describes Treprostinil, an inhalation solution that is an FDA-approved final product, non-compounded, administered through DME in unit dose form at a dosage of 1.74 mg.